| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/19/2011 | US7981660 Methods for producing modified glycoproteins |
| 07/19/2011 | US7981655 Modified cytosine deaminases |
| 07/19/2011 | US7981652 Modified cytochrome P450 monooxygenases |
| 07/19/2011 | US7981651 Lactobacillus acidophilus nucleic acids and uses thereof |
| 07/19/2011 | US7981637 Fluorescent protein and chromoprotein |
| 07/19/2011 | US7981636 Enzymes for use in enzymatic bleaching of food products |
| 07/19/2011 | US7981635 Cleavage of precursors of insulins by a variant of trypsin |
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981617 Transcription template for cell-free protein synthesis and method using the same |
| 07/19/2011 | US7981614 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/19/2011 | US7981601 Method of preparing polyepitope chimeric gene vaccine |
| 07/19/2011 | US7981434 Surface exposed immunoglobulin D-binding protein from Moraxella catarrhalis |
| 07/19/2011 | US7981429 Influenza hemagglutinin and neuraminidase variants |
| 07/19/2011 | US7981427 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
| 07/19/2011 | US7981424 RAGE fusion proteins, formulations, and methods of use thereof |
| 07/19/2011 | US7981423 Rage fusion proteins |
| 07/19/2011 | US7981419 Method for treating hypophosphatemic bone diseases using FGF-23 antibody |
| 07/19/2011 | US7981417 Blood-brain barrier targeting anti-bodies |
| 07/19/2011 | US7981416 Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency |
| 07/19/2011 | US7981414 Anti-inflammatory dAb |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | US7981398 PEGylation by the dock and lock (DNL) technique |
| 07/19/2011 | CA2599914C Lectin isolated from bryopsis maxima that binds high-mannose-type sugar chains, used to purify chicken antibodies |
| 07/19/2011 | CA2477232C Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 07/19/2011 | CA2435606C Expression of recombinant proteinase k from tritirachium album in yeast |
| 07/19/2011 | CA2433501C Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/19/2011 | CA2401906C Kcnb: a novel potassium channel protein |
| 07/19/2011 | CA2348025C Genes encoding proteins regulating ph of vacuoles |
| 07/19/2011 | CA2185656C Protein tyrosine kinase agonist antibodies |
| 07/19/2011 | CA1341618C Isolation cloning and expression of primate gm-csf |
| 07/14/2011 | WO2011085095A2 Enhanced protein expression |
| 07/14/2011 | WO2011084695A1 Methods for producing heterologous polypeptides in thiol-disulfide oxidoreductase-deficient bacterial mutant cells |
| 07/14/2011 | WO2011084145A2 Recombinant butyrylcholinesterases and truncates thereof |
| 07/14/2011 | WO2011083356A1 Process for the specific isotopic labeling of methyl groups of val, leu and ile |
| 07/14/2011 | WO2011083059A1 Bacterial mutants and uses thereof in protein production |
| 07/14/2011 | WO2011062997A3 Human monoclonal antibodies to human nucleolin |
| 07/14/2011 | US20110173722 Novel insulin derivatives having an extremely delayed time-action profile |
| 07/14/2011 | US20110172406 Molecular structure of rhd negative |
| 07/14/2011 | US20110172399 Il-21 antagonists |
| 07/14/2011 | US20110172170 Interferon-like protein zcyto21 |
| 07/14/2011 | US20110172139 Peptides whose uptake by cells is controllable |
| 07/14/2011 | US20110172123 Arrays |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171753 Modified anti-heparin/pf4 complex antibody and hit antibody standard |
| 07/14/2011 | US20110171751 Recombinant polypeptides for diagnosing infection with trypanosoma cruzi |
| 07/14/2011 | US20110171690 Angiotensin converting enzyme inhibitory peptide |
| 07/14/2011 | US20110171689 Artificial immune system: methods for making and use |
| 07/14/2011 | US20110171688 Method of providing immunoglobulin secreting b lymphocytes and human antibodies |
| 07/14/2011 | US20110171687 Unstructured recombinant polymers and compositions comprising same |
| 07/14/2011 | US20110171686 Reverse cumate repressor mutant |
| 07/14/2011 | US20110171627 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods |
| 07/14/2011 | US20110171316 Expression and assembly of human group c rotavirus-like particles and uses thereof |
| 07/14/2011 | US20110171263 Compositions and methods of use of orf-1358 from beta-hemolytic streptococcal strains |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171231 ANTI-PlGF ANTIBODIES AND METHODS USING SAME |
| 07/14/2011 | US20110171226 Novel Subtype of Closteridium Botulinum Neurotoxin Type A and Uses Thereof |
| 07/14/2011 | US20110171222 Anti-her3 antibodies and uses thereof |
| 07/14/2011 | US20110171218 Compositions and methods for increasing serum half-life |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171198 Highly functional enzyme having alpha-galactosidase activity |
| 07/14/2011 | US20110171179 Method for Regulating Production of Hemoglobin Beta Chains |
| 07/14/2011 | US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities |
| 07/14/2011 | CA2786272A1 Process for the specific isotopic labeling of methyl groups of val, leu and ile |
| 07/14/2011 | CA2785195A1 Novel bacillus thuringiensis gene with coleopteran activity |
| 07/13/2011 | EP2343380A1 Immunoglobulin variable region cassette exchange |
| 07/13/2011 | EP2343378A1 Production of high mannose proteins in plant culture |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2342350A1 Method for polyclonal immunoglobulin g production by human b cells |
| 07/13/2011 | EP2342335A1 Novel gene cluster |
| 07/13/2011 | EP2342224A2 Novel vectors for production of interferon |
| 07/13/2011 | EP2342223A2 Modified animal erythropoietin polypeptides and their uses |
| 07/13/2011 | EP2143438B1 Compositions and methods for the diagnosis and treatment of tumors |
| 07/13/2011 | EP2019864B1 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
| 07/13/2011 | EP1647593B1 Method for producing l-histidine using bacteria of the enterobacteriaceae family |
| 07/13/2011 | CN102124121A Production of cellulase enzymes in plant hosts using transient agroinfiltration |
| 07/13/2011 | CN102124105A Antibody capable of binding specifically to Abeta-oligomer, and use thereof |
| 07/13/2011 | CN102121040A Method for preparing glutamine active peptide by enzyme method in ethanol system |
| 07/13/2011 | CN102121039A Preparation method of plant immune protein |
| 07/13/2011 | CN102121029A Plant expression vector and construction method thereof, and method for producing chicken alpha interferon by utilizing crowtoe as bioreactor |
| 07/13/2011 | CN102121023A Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/13/2011 | CN102120967A Preparation and application of OCH1 genetic flaw type P. pastoris X-33 bacterial strain |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/13/2011 | CN101168763B Method for preparing nano natural silk protein powder |
| 07/13/2011 | CN101081232B Yak bone marrow glair polypeptides bone extract and the composition thereof and the preparing method |
| 07/12/2011 | US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 07/12/2011 | US7977464 Antibody molecules specific to human tumour necrosis factor alpha |
| 07/12/2011 | US7977462 Tyrosine phosphorylation sites |
| 07/12/2011 | US7977461 Anti-platelet membrane glycoprotein VI monoclonal antibody |
| 07/12/2011 | US7977314 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 07/12/2011 | US7977312 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 07/12/2011 | US7977097 Method of screening multiply transformed cells using bicistronic expression of fluorescent proteins |
| 07/12/2011 | US7977091 Eukaryotic layered vector initiation systems |
| 07/12/2011 | US7977079 Nucleic acid constructs encoding cytotoxic ribonuclease variants |
| 07/12/2011 | US7977077 Synthesis of intermediates of oseltamivir carboxylates |
| 07/12/2011 | US7977073 Polynucleotide encoding a thermostable amide hydrolase and methods for producing an L-α-amino acid |